New Research To Be A Big Boost For Stem Cell Scientists

A U.S. scientist team has identified phosphorylated signaling proteins in human embryonic stem cells (hESCs).

A U.S. scientist team has identified phosphorylated signaling proteins in human embryonic stem cells (hESCs). The study may help understand the mechanisms that determine whether stem cells divide or differentiate, what types of cells they become, and how to control those complex mechanisms to facilitate development of new therapies.

Researchers a the Burnham Institute for Medical Research (Burnham) and The Scripps Research Institute (TSRI) say that protein phosphorylation, the biochemical process that modifies protein activities by adding a phosphate molecule, is central to cell signaling.

Stem Cells Made from Developing Sperm by Johns Hopkins Researchers
Uncovering how adult cells revert back into a primordial, stem cell state is one of the key steps in bringing to fruition the promise of stem cell therapy.

Writing about their study in the journal Cell Stem Cell, the researchers said that they used sophisticated phosphoproteomic analyzes to cataloged 2,546 phosphorylation sites on 1,602 phosphoproteins.

They say that before their study, protein phosphorylation in hESCs was poorly understood.

According to them, identification of these phosphorylation sites provides insights into known and novel hESC signaling pathways and highlights signaling mechanisms that influence self-renewal and differentiation.

Common Trigger in Cancer and Normal Stem Cell Reproduction Discovered by Stanford Scientists
A common molecular pathway is used by both normal stem cells and cancer stem cells when they reproduce themselves, researchers at Stanford University School of Medicine have discovered

"This research will be a big boost for stem cell scientists. The protein phosphorylation sites identified in this study are freely available to the broader research community, and researchers can use these data to study the cells in greater depth and determine how phosphorylation events determine a cell's fate," said Dr. Laurence M. Brill, senior scientist at Burnham's Proteomics Facility.

With this knowledge, according to the team, stem cell researchers may be able to develop more focused methods to control hESC differentiation and move closer to clinical therapies.

Research Says Gene Signature for Cancer Stem Cells may Provide Drug Targets
Tumor cells that remain after a woman with breast cancer undergoes treatment with either anti-cancer or anti-hormone therapy shows a gene signature

Source-ANI
ARU